Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 261

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes

Open access
Wheeler, Matthew T., Heidenreich, Paul A., Froelicher, Victor F., Hlatky, Mark A., Ashley, Euan A. · 2010 · Annals of Internal Medicine

Abstract

BACKGROUND: Inclusion of 12-lead electrocardiography (ECG) in preparticipation screening of young athletes is controversial because of concerns about cost-effectiveness. OBJECTIVE: To evaluate the cost-effectiveness of ECG plus cardiovascular-focused history and physical examination compared with cardiovascular-focused history and physical examination alone for preparticipation screening. DESIGN: Decision-analysis, cost-effectiveness model. DATA SOURCES: Published epidemiologic and preparticipation screening data, vital statistics, and other publicly available data. TARGET POPULATION: Competitive athletes in high school and college aged 14 to 22 years. TIME HORIZON: Lifetime. PERSPECTIVE: Societal. INTERVENTION: Nonparticipation in competitive athletic activity and disease-specific treatment for identified athletes with heart disease. OUTCOME MEASURE: Incremental health care cost per life-year gained. RESULTS OF BASE-CASE ANALYSIS: Addition of ECG to preparticipation screening saves 2.06 life-years per 1000 athletes at an incremental total cost of $89 per athlete and yields a cost-effectiveness ratio of $42 900 per life-year saved (95% CI, $21 200 to $71 300 per life-year saved) compared with cardiovascular-focused history and physical examination alone. Compared with no screening, ECG plus cardiovascular-focused history and physical examination saves 2.6 life-years per 1000 athletes screened and costs $199 per athlete, yielding a cost-effectiveness ratio of $76 100 per life-year saved ($62 400 to $130 000). RESULTS OF SENSITIVITY ANALYSIS: Results are sensitive to the relative risk reduction associated with nonparticipation and the cost of initial screening. LIMITATIONS: Effectiveness data are derived from 1 major European study. Patterns of causes of sudden death may vary among countries. CONCLUSION: Screening young athletes with 12-lead ECG plus cardiovascular-focused history and physical examination may be cost-effective. PRIMARY FUNDING SOURCE: Stanford Cardiovascular Institute and the Breetwor Foundation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-152-5-201003020-00005

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 81 references

Cited by

See all 261

Metadata

Authors
Wheeler, M. T., Heidenreich, P. A., Froelicher, V. F., Hlatky, M. A., & Ashley, E. A.
Venue
Annals of Internal Medicine
Published
2010-03-02
Volume
152
Issue
5
Pages
276-286
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2097775346
Cited by
261
References
81
FWCI
24.73
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes. https://app.cochat.ai/papers/10.7326/0003-4819-152-5-201003020-00005
The paper
Wheeler, M. T., Heidenreich, P. A., Froelicher, V. F., Hlatky, M. A., & Ashley, E. A. (2010). Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-152-5-201003020-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.